Low HR and thus good prognosis was associated with enhanced GPCR methylation (spot B’) in NL (M6), IDH-O (M5), and also in M4 tumors, which enrich lower-grade II IDH-A gliomas. This evidence concerns the gene IDH1 and glioma.